コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 imum inactivation (V ), without changing the slope factor.
2 tivation that was accompanied by a change in slope factor.
3 s, defined by half-activation potentials and slope factors.
4 still depend on contentious PEFs and cancer slope factors.
8 pplied mixed-effects models, and we computed slope factor, d[PbB]/d[PbA] or the change in PbB per uni
10 ce calcium-activated potassium channels, the slope factor derived from the Hill equation was signific
11 o 71 +/- 10 (P < 0.01) whereas for K525C the slope factor did not change (18 +/- 2 at baseline and 16
13 WT and L529I showed no difference in the slope factor in the absence of NS1643 (8 +/- 0 vs. 9 +/-
15 ts with those from the literature shows that slope factor increased with decreasing PbA among childre
17 lf-activation potential is V(a)=-52.5mV with slope factor k(a)=16.5mV, whereas for inactivation the c
23 etion was fitted by the Hill equation with a slope factor of 2.5 and half-maximal activation at 1.6 m
24 ming lifetime exposure and a proposed cancer slope factor of 25.7 per milligram per kilogram of body
25 steeply voltage dependent, with a Boltzmann slope factor of 5 mV, a midpoint near -45 mV (5 sec cond
27 34 +/- 5, respectively) but with NS1643, the slope factor of K525C/L529I increased from 34 +/- 5 to 7
28 (9 vs. 8) but in the presence of NS1643, the slope factor of K525R was increased to 24 +/- 4 vs. 9 +/
29 red the voltage dependency and the values of slope factor of NLC and somatic motility simultaneously
32 pendent, with half-inactivation voltages and slope factors of -35.1+/-1.3 and -5.4+/-0.4 mV at 37 deg
34 We showed that the voltage dependency and slope factors of NLC and motility were not statistically
35 t activated over the same voltage range with slope factors of their peak conductance-voltage (G-V) re
38 alues (RfVs) for noncancer effects, and oral slope factors (OSFs) for cancer-that are available for a
39 current characterized by E(rev), V(1/2), and slope factor remained unchanged when co-expressed with S
41 with an EC(50) value of 1.6 +/- 0.3 microM (slope factor was 1.2 +/- 0.1, n = 4 to 5 cells per conce
42 80-kg adult, and a recently proposed cancer slope factor, we estimated that use of nitarsone by all
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。